newsfilter
← Latest News
PR Newswire·

Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered ...